Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published 13 May 2025 and 26 May 2025 (after correction: 13 May 2025)The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Revenue fell below plan due to delays in the announcement of bidding projects, orders shifting into a different fiscal period, shortfalls in orders for the healthcare BPO business, and the failure to launch replacement projects after the suspension of SoftBank’s contract solicitation services. Profit also fell below forecast due to increased competition, higher personnel expenses, costs related to simplified share delivery, provisions for doubtful accounts, site closure costs and the reversal of deferred tax assets, among other factors.
¥75 million in fees for external advisers, attorneys and others associated with simplified share delivery; approximately ¥15 million in provisions for doubtful accounts; approximately ¥20 million in site closure costs related to the termination of SoftBank’s contract solicitation services; approximately ¥30 million in income tax adjustments resulting from the reversal of deferred tax assets; approximately ¥7 million on the disposal of fixed assets; and approximately ¥8 million in impairment losses on shares related to a reassessment of a subsidiary’s valuation. In addition, a ¥16 million gain on the partial transfer of the healthcare BPO business was recognized.
| Item | Details |
|---|---|
| Net Sales | ¥2,600 million → ¥2,133 million（-17.9%） |
| Operating profit | ¥135 million → ¥-171 million |
| Ordinary income | ¥105 million → ¥-196 million |
| Profit attributable to owners of the parent | ¥60 million → ¥-232 million |
| Net income per share | 24.07 yen and sen → -98.07 yen and sen |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 13 May 2025 and 26 May 2025 (after correction: 13 May 2025) |
| Previous-period results | Fiscal year ended March 2025: revenue ¥2,544 million, operating profit ¥21 million, ordinary profit ¥15 million, net loss attributable to owners of parent ¥414 million, and loss per share ¥169.34 |
| Reason for the revision | Revenue fell below plan due to delays in the announcement of bidding projects, orders shifting into a different fiscal period, shortfalls in orders for the healthcare BPO business, and the failure to launch replacement projects after the suspension of SoftBank’s contract solicitation services. Profit also fell below forecast due to increased competition, higher personnel expenses, costs related to simplified share delivery, provisions for doubtful accounts, site closure costs and the reversal of deferred tax assets, among other factors. |
| Details and amount of extraordinary loss | ¥75 million in fees for external advisers, attorneys and others associated with simplified share delivery; approximately ¥15 million in provisions for doubtful accounts; approximately ¥20 million in site closure costs related to the termination of SoftBank’s contract solicitation services; approximately ¥30 million in income tax adjustments resulting from the reversal of deferred tax assets; approximately ¥7 million on the disposal of fixed assets; and approximately ¥8 million in impairment losses on shares related to a reassessment of a subsidiary’s valuation. In addition, a ¥16 million gain on the partial transfer of the healthcare BPO business was recognized. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue fell below plan due to delays in the announcement of Japanese-language bidding projects by government ministries and local authorities, orders shifting into a different fiscal period, shortfalls in orders for the healthcare BPO business, and the suspension of SoftBank’s contract solicitation services before replacement projects could be launched. Profit was also weighed down by increased competition, higher personnel expenses, costs associated with simplified share delivery, provisions for doubtful accounts, site closure costs and the reversal of deferred tax assets, among other factors.